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Abstract 
 
Fungal infections are caused by a variety of fungi, and with a variety of clinical manifestations.  
Antifungal treatments are limited due to host toxicity and fungi gaining resistance.  By utilizing the 
model organism Saccharomyces cerevisiae, we hope to elucidate the molecular mechanisms of fungal 
pathogenesis that we can then validate in the human pathogen Candida albicans, as well as explore 
options for novel therapies. 
 
Small molecule signaling is a method by which single-cell organisms can communicate with one 
another, enabling them to coordinate gene expression.  This is a useful tool because it allows microbes 
to turn on phenotypes that are only valuable when done in large numbers, such as bioluminescence, 
or virulence traits.  We have previously shown that the yeast Saccharomyces cerevisiae synthesizes the 
secondary metabolite indole-3-acetic acid (IAA) from tryptophan.  IAA is secreted into the 
environment, where it acts as a signal.  At low concentrations, the IAA signals yeast to induce 
virulence traits, while at high concentrations, it is lethal.     
 
The purpose of this thesis was to investigate the molecular mechanism of IAA (plant hormone auxin) 
regulation in fungi, specifically, Saccharomyces cerevisiae and the human pathogen Candida albicans.  
Towards this end, I first focused my efforts on evaluating the role of S. cerevisiae Grr1, as a putative 
IAA receptor.  By evaluating the IAA response of several Grr1 mutants, I was able to show that the 
leucine-rich repeat region, while not required for function, likely plays a significant role in maintaining 
the structural integrity of the protein.  Next, I evaluated IAA associated phenotypes, such as 
filamentation, surface adhesion and IAA uptake of grr1Δ/Δ mutant in the human pathogen Candida 
albicans.  Together, these data support the hypothesis that GRR1 regulates IAA response, probably by 
regulating the IAA uptake carriers.  
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Introduction 
Fungal Pathogenesis 
Fungal diseases are a worldwide public health issue.  The illnesses caused by fungi can range from 
superficial (athlete’s foot), to deadly (blood stream infections).  The three general classes of infections 
that the Mycotic Diseases branch of the Centers for Disease Control is concerned about are 
opportunistic infections, community acquired infections, and hospital acquired infections [1]. 
 
Opportunistic infections refer to infections that do not generally harm healthy individuals, but can 
cause massive damage to immunocompromised patients, including those with AIDS, individuals 
undergoing chemotherapy, or organ recipients.  Some opportunistic infections are cryptococcal 
meningitis (caused by C. neoformans) and aspergilliosis (lung infection caused by Aspergillus species).  
Cryptococcal meningitis is one of the leading causes of death in HIV patients, and is a serious problem 
for other immunocompromised populations, while Aspergilliosis can be especially difficult in people 
with cystic fibrosis [1]. 
 
The second class is community acquired infections.  These generally are caused by fungal spores that 
reside in soil.  When the soil is disrupted, people inhale the spores, resulting in diseases such as 
blastomycosis, histoplasmosis, and coccidiomycosis (valley fever) [1].  Blastomycosis is caused by 
Blastomyces dermatitidis spores.  Typically, the spores remain inactive in the host.  Histoplasmosis is 
caused by Histoplasma capsulatum spores, and typically affects the lungs.  This can be a severe 
problem for immunocompromised individuals, such as AIDS patients.  Valley fever is caused by spores 
from Coccidioides species.  The result is pneumonia, which is self-limiting.  Overall, current antifungal 
drugs are capable of treating most infections in this class. 
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Figure 1: Fungal cell membrane and cell wall.  
Fungal-specific features include beta- (1,6) 
glucan, beta-(1,3)-glucan, chitin, ergosterol and 
squalene.  (Image Courtesy of www.doctorfungus.org © 
2005) 
The last class is hospital acquired infections.  The fourth most common cause of hospital-acquired 
infections is Candida species in the bloodstream (bloodstream infection) [2].  Candida albicans is the 
most prevalent fungal pathogen of humans.  It is responsible for common clinical problems including 
oral thrush and vaginitis, but can also lead to life-threatening systemic infections in 
immunocompromised individuals, such as AIDS patients, resulting in 30-50% mortality rates.  Overall, 
in the US alone, there are estimated to be about 10,000 deaths per year due to Candida infections.  
The estimated annual cost of treating nosocomial Candida infections exceeds $1 billion per year [3].  
While several species of Candida are responsible for the deadly bloodstream infections, C. albicans is 
responsible for almost half (46%) [2].  For these reasons, we have chosen to focus our investigation of 
C. albicans. 
 
Antifungal Agents 
Treating fungal infection poses a unique challenge as fungi are eukaryotes.  As such, they have much 
more in common with humans than the prokaryotic bacteria that colonize humans to cause infection, 
making finding drug targets substantially more 
difficult.  Currently, anti-fungal drugs target 
fungus-specific pathways, in order to attack the 
fungi and not the human host.  One of the major 
differences between fungal and human cells is 
the presence of a cell wall (Figure 1).  The 
current drugs available to treat Candida 
infections in humans generally target the cell 
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Figure 3: Structural similarity between 
cholesterol and ergosterol.  Many antifungal 
drugs target ergosterol.  Because ergosterol is 
extremely similar to cholesterol, host toxicity is 
observed at low concentrations. (Image Courtesy of 
www.doctorfungus.org © 2005) 
wall, or membrane, and can be classified into 4 main categories, based on their mechanism of action; 
polyenes, azoles, echinocandins and allylamines.   
 
 (i) Polyenes 
Polyenes, such as nystatin and amphotericin B, 
work by associating with ergosterol, and 
creating a porous channel through the cell 
wall (Figure 2).  The result is that the 
membrane potential is lost, as monovalent 
cations leave the cells, resulting in yeast cell 
death [4].  Currently, very few Candida strains 
are resistant to polyenes.  The few that are 
resistant have a defect in the ERG3 gene, 
responsible for ergosterol synthesis.  These 
strains have an increased proportion of other sterols in the cell wall [5].  
 
Ergosterol is very similar in structure to cholesterol (Figure 3).  This structural similarity means that at 
high doses, polyene drugs can be toxic to human cells containing cholesterol [6].  The result is that 
these drugs can only be used at low concentrations, limiting their efficacy as an antifungal agent.   
Figure 2: Mechanism of polyene drug action.  Polyenes 
associate with ergosterol to create pores in the cell 
membrane through which cations leave the cell, 
resulting in the loss of membrane potential. (Image 
Courtesy of www.doctorfungus.org © 2005) 
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Figure 4: Mechanism of azole drug action.  
When azoles are present, 14-alpha-demethylase 
is inhibited, resulting in the accumulation of 
toxic sterols in the cell membrane, leading to cell 
death. (Image Courtesy of www.doctorfungus.org © 
2005) 
 
 
(ii) Azoles 
Azoles, such as fluconazol and itraconazol, work by interfering with the synthesis of ergosterol in the 
cell membrane, leading to the accumulation of toxic sterols in the membrane (Figure 4).  Fluconazole 
resistant Candida strains are exceptionally prevalent; up to 1/3 of AIDS patients suffer oral thrush 
caused by azole resistant C. albicans strains [5].  There are multiple mechanisms by which Candida 
gain resistance to azoles, outlined below.  One 
species may use more than one mechanism, and 
they are thought to function in an additive 
manner [5]. 
 
One method by which Candida species evade the 
effects of azoles is by decreasing the intracellular 
drug concentration by the use of efflux pumps.  
Two of these are the Cdr pumps, and the Mdr 
pumps.  It has been shown that CDR1 and CDR2 
are upregulated in azole resistant strains of C. 
albicans, and MDR1 is upregulated in (specifically) 
fluconazole resistant strains [7]. 
 
Another mechanism used by Candida to resist the effects of azoles is alteration of the enzyme that 
azoles target.  Azoles function by binding to lanosterol C-14-alpha-demethylase, an enzyme critical to 
the synthesis of ergosterol in the cell membrane.  It has been observed that some azole-resistant 
strains of Candida have a mutated ERG11 gene, which is responsible for the synthesis of lanosterol C-
10 
 
Figure 5: Mechanism of echinocandin drug action.  
Echinocandins inhibit beta(1,3)-glucansynthetase 
action.  This destabilizes the cell wall, leading to cell 
death. (Image Courtesy of www.doctorfungus.org © 2005) 
14-alpha-demethylase [5].  Additionally, the ERG11 gene may simply be up-regulated, thereby 
diminishing the effects of the drug [8]. 
 
Lastly, as stated above, Candida with a defect in the ERG3 gene, responsible for ergosterol synthesis, 
have been found to have membranes with very little ergosterol.  This makes them resistant to 
polyenes, and also makes them resistant to azoles. 
 
(iii) Echinocandins 
Echinocandins, such as caspofungin, are less 
well understood than the aforementioned 
classes.  They are believed to work by targeting 
the catalytic subunit of 1,3 beta 
glucansynthetase, which is involved in cell wall 
formation (Figure 5).  When cell wall formation 
is disrupted in this manner, the cells lyse.  
Resistance to this class of drugs is rare, but it 
has been noted that resistant strains have 
amino acid substitutions between residues 641-
649 and 1257-1364 of the catalytic subunit [7].   
 
(iv)  Allylamines 
The last major class of antifungal drugs is allylamines, including naftifine and terbinafine.  These drugs 
work by inhibiting ergosterol synthesis[6].  Specifically, they inhibit squalene epoxidation, one of the 
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first steps in ergosterol synthesis.  The result is two-fold; squaline builds up to toxic levels inside the 
cells, and the cell walls are weakened due to lack of ergosterol.  Squalene is an exclusively fungal 
protein, which makes it an excellent drug target.  Resistance, however, has been achieved by the use 
of CDR efflux pumps, just as in azole resistant strains [9].  
 
While all of these classes of drugs work in a slightly different manner, they all target the cell 
membrane or cell wall.  More importantly, yeast have developed methods to evade all of these.  This 
is, in part, because the drugs must enter the cells to work, and once the drug is in, there is selective 
pressure to destroy it, or work around it.  A novel, exclusively fungal target is needed, in order to 
intelligently craft drugs that can fight yeast infections in humans.  This thesis explores one such 
avenue: targeting secondary metabolite signaling. 
 
Disease Progression 
Many fungi are normal, commensal human microflora found in the gastrointestinal and urogenital 
tract, but frequently become problematic, particularly when the host is immunocompromised [3].  
Candida species can somehow “sense” that the environment is optimal for invasion and then express 
adhesins, which help them adhere to the epithelium of mucosal membranes, such as the oral cavity 
and vaginal tract, as well as the plastics used for catheterization [10].  This is the first step of infection 
[10].  One of the better understood classes of adhesins is the agglutinin-like sequence (Als) 
glycoproteins.   
 
There are 8 known Als proteins in C. albicans, and each is unique in its substrate affinity which is 
determined by the N-terminal region.  For instance, the ALS1 and ALS3 genes encode proteins that are 
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particularly efficient at binding endothelial cells, and epithelial cells, respectively [11].  Additionally, 
the Als proteins are very well conserved, which means that an antibody that targets one, may well 
target others, too.  Vaccines of this variety would work by inhibiting the ability of the Candida to 
adhere to cells, which results in the halt of disease progression.  The Edwards lab at UCLA has shown 
that vaccination of mice with recombinant N-terminal sequences of both Als1 and Als3 provides 
protection against bloodstream infections, as well as oropharyngeal and vaginal Candida infections 
[12] 
 
Once the Candida have adhered, alternative proteins are expressed, and they begin to invade into the 
vascular space beneath the membrane.  This is believed to be accomplished, in part, by the secretion 
of enzymes, such as secreted aspartyl proteases (SAPs), which are believed to help to break down the 
host cell membrane [13].  In further support of the role of SAPs in disease progression, researchers 
have found that vaccination targeting SAP2 has reduced the fungal load of mice infected with Candida 
bloodstream infections [14].  This is proposed to be due to the antibodies interfering with the 
enzymes’ activity, as no signs of increased host immunity are present in these animals [14]. 
 
Another contributing factor to invasion of tissue is the dimorphic switch from yeast form to hyphal 
form.  The hyphae, or filaments, are a foraging response.  When the fungi are starved, or otherwise 
stressed, they respond by extending these protrusions in an attempt to secure nutrients.  In the 
process of doing this, they penetrate the host membrane, gaining them access to the bloodstream 
[15].  In the lab, this phenotypic switch can be observed by microscopy.  One challenge researchers 
face is controlling for the many known filamentation inducers, from pH, temperature and Ca2+ 
concentration, to carbon and nitrogen source, as well as many others [16].  For example, IAA has been 
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shown to induce filamentation in S. cerevisiae, but the concentration required to do so can vary 
immensely depending on the media.  For instance, in rich media (such as YPD) up to 1.5 mM IAA can 
be required to induce filamentation, while as little as 20 µM IAA may be sufficient in minimal media 
with an alternative glucose source (such as SLAD plates).   
 
Once the Candida have penetrated the membrane, they are exposed to the bloodstream where are 
disseminated throughout the body, leading to death in 30-50% of infected AIDS patients.  When in the 
bloodstream, Candida have been shown to bind to plasmin (the active form of plasminogen), which 
grants them the ability to cross an in vitro blood-brain barrier.  Additionally, when bound, the Candida 
are able to enhance fibrinolysis [17]. 
 
Small Molecule Signaling 
A new approach to combating fungal infections is to manipulate their environment, in order to “trick” 
them into turning virulence traits off.  If the small molecule used to communicate were somehow 
removed from the environment, or inactivated, the signal to activate virulence could potentially be 
disrupted.   Microbes use small molecules to synthesize environmental information.  The microbes are 
able to synthesize, secrete, recognize and respond to these small molecule signals, in a population-
dependent manner [18].  This phenomenon has been very well studied in bacteria.  The first described 
system is Vibrio fischeri.  These bacteria naturally reside in the light organ of the Hawaiian squid 
Euprymna scolopes. Here, the bacteria multiply to exceptionally high numbers, resulting in the 
accumulation of high concentrations of the signaling molecules autoinducers 1 and 2 (AI1 and AI2).  In 
turn, the AI molecules cause the expression of genes required for the production of bioluminescence.  
At regular intervals, the squid excretes almost all of the bacteria.  The remaining bacteria lack 
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Figure 6: Small molecule signaling model.  When 
microbes (blue ovals) reach a certain threshold density, 
enough of the small signaling molecule (purple triangles) 
accumulates, activating alternative gene expression.  This 
results in such phenotypes as bioluminescence, or 
virulence traits.   
 
 
Low Population 
Density 
 
High Population Density 
 
  
 
sufficient signaling molecule to continue to express the bioluminescence genes.  The population 
increases again, until critical mass is reached, and the cycle continues (Figure 6) [19].  This is beneficial 
for both the squid, and the bacteria.  The bacteria are housed in a nutrient rich, relatively safe 
environment, where they are able to multiply to levels much higher than achievable in the ocean.  
Meanwhile, the squid uses the light that is produced for counter-illumination which protects it from 
predators.   
 
It is important to note that if only a single 
bacterium turned on these genes, it would not 
help the squid, and it would cost the bacterium 
a great deal of energy.  Thus, this ability to 
regulate the expression in a population-
density dependent manner is beneficial for all 
parties involved.  
 
While this example showcases the use of small molecule signaling as a symbiotic relationship, not all 
cases are beneficial for both parties.  For example, the gram positive bacteria Staphylococcus aureus is 
part of normal human microflora.  However, it is capable of using a small molecule, autoinducing 
peptide (AIP), to signal the secretions of deadly toxins [20].  Strains of S. aureus are classified based on 
the sequence of their AIP.  Each strain's AIP is capable of eliciting response from its own species, while 
simultaneously inhibiting the pathways of the other species [20].  This ability to tell “kin” from “other” 
has very relevant clinical applications; it has been shown that S. aureus AIPII can be used to stop 
virulence progression of S. aureus I in mouse models [20].   
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While small molecule signaling has been well described in bacteria for more than 20 years, it has not 
been nearly as well studied in fungi.  One well known cell density dependent phenotype in C. albicans 
is the long lag period before exponential growth observed when cells are diluted in fresh media.  If the 
cells are diluted with conditioned media, this lag period is eliminated [21].  This observation suggests 
that there is some compound being synthesized by the yeast, and secreted into their environment 
that allows rapid exponential growth.  It was determined that this compound is tyrosol [21].  
Additionally, transcriptional profiling revealed that DNA-replication machinery and cell-cycle-control 
protein transcripts decline rapidly after dilution.  Two major hypotheses to explain these phenomena 
have been proposed; tyrosol may help to control transcription of these genes, or, it could stabilize the 
transcripts after dilution. 
 
Another phenotype observed in response to tyrosol is the phenotypic switch from cellular yeast form 
to invasive filamentous form, when cells are grown in permissive media (minimal, increased pH and 
increased temperature condition).  This is believed to be as a result of the increased growth rate; 
tyrosol allows the cells to grow more quickly, thus synthesizing components more readily, resulting in 
the ability to form the filamentous protrusions.   
 
Another compound that is related to this dimorphic phenotypic switch is farnesol.  It has been shown 
that farnesol accumulates in the media at a rate that is roughly proportional to the number of cells 
present [15].  As is accumulates, it acts to suppress the switch to filamentous phenotype, even when 
grown in conditions favoring filamentation, such as the addition of serum [15].  In this way, it counter 
acts the effects of tyrosol. 
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Figure 7:  Fungal cell morphology.  S. cerevisiae and C. 
albicans both exist in yeast and pseudohyphal form, but 
only C. albicans forms true hyphae. 
 
Together, tyrosol and farnesol, and other secondary metabolites, such as IAA work to regulate the 
hyphal transition from yeast form to filamentous form in C. albicans.  Tyrosol allows the cells to grow 
more rapidly, and allows the yeast cells to filament, while farnesol suppresses this effect, resulting in 
yeast cell morphology.  This complex regulation of hyphal formation is only one way in which fungi use 
small molecule signaling to control gene expression. 
 
The morphological transition, from the round yeast morphology, to the filamentous morphology is 
vital for disease progression.  As noted earlier, hyphae formation is crucial for penetration through the 
host cellular membrane, a key step in disease progression.  Fungi can exist in various forms (Figure 7), 
which can be induced by a variety of stimulators.  S. cerevisiae and C. albicans can both exist in the 
yeast form, where mother and daughter cells fully separate during replication, resulting in two new, 
round yeast cells.  Both fungi can also 
exist in a pseudohyphal form, where the 
daughter cells do not quite separate 
after cytokinesis, resulting in a chain of 
elongated cells.  C. albicans, but not S. 
cerevisiae can also form true hyphae 
(also known as filaments or mycelia).  In 
this form, single cells grow into 
elongated tubes, without constriction 
indicating incomplete separation after cytokinesis [3] [22].  It is generally believed that the yeast form 
is most prevalent in bloodstream infections, where the yeast get carried throughout the body, while 
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the hyphal and pseudohyphal forms are most prevalent in superficial infections, and biofilm 
formation. 
 
In order to identify other signaling molecules responsible for the morphological transition, a chemical 
screen was performed.  More than 50 chemicals were tested in order to find out which, if any, caused 
a phenotypic change [18].  Indole-3 acetic acid (IAA) was identified as one such compound. 
 
Targeting the very molecule that fungi use to communicate may be an alternative way to treat fungal 
diseases.  It is particularly appealing for resistant strains, because the resistance they have gained by 
substituting ergosterol in the membrane, or pumping drugs out of the cell would be useless against a 
drug that was active outside the cell.  IAA may be one such molecule. 
 
IAA: A Small Signaling Molecule 
One of the oldest interests of plant biologists is the role of the auxin (IAA) in planta.  As early as the 
late eighteen hundreds, Charles Darwin postulated that a substance which regulates growth must 
exist in plant cells [23].  About sixty years later, indole-3-acetic acid (IAA) was discovered to be the 
signaling molecule responsible for the growth inhibition of the primary root, the stimulation of lateral 
root initiation, and adventitious rooting.  This directional growth is accomplished through the use of 
auxin concentration minima and maxima, and is important as it allows the plants to branch out their 
roots, increasing their ability to acquire nutrients and water [24].  
 
Very shortly after IAA was isolated from plants, scientists began looking into whether IAA was 
synthesized in other organisms- namely, fungi.  As early as 1959, Gruen reported that 67, out of 75 
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species of fungi that were screened, synthesized IAA.  Since then, it has been determined that the 
most preserved biosynthetic pathway for the synthesis of IAA uses tryptophan as a precursor, but 
many species of fungi, including Saccharomyces cerevisiae have alternate, tryptophan-independent 
biosynthetic pathways [25].   
 
One possible explanation for the relationship between the production of a plant hormone in fungi is a 
pathogen-host relationship [18].  In nature, yeast grow on, and eat from, the fruit of many plants.  As 
such, it is beneficial to the yeast to be able to sense when a plant is wounded, as it means the yeast 
would benefit from growing directionally towards the wound-site, where the glucose is spilling from 
the plant.  However, this increased growth of yeast when a plant is wounded is detrimental to the 
plant.  A beneficial trait for the plant would be the ability to suppress the growth of yeast, particularly 
when wounded. 
 
It has been observed that when yeast are exposed to IAA at low levels, a phenotypic switch occurs and 
pseudohyphal growth is observed, while at high levels of IAA growth is inhibited (Figure 8) [18].  These 
observations support the hypothesis that yeast and plants use IAA to communicate, to benefit 
themselves.  What is yet to be understood is the molecular mechanism by which the IAA signal is 
transduced into a pathogenic phenotype.  
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Molecular Mechanism of IAA Signaling 
In order to better understand the role of IAA in pathogenesis, Saccharomyces cerevisiae was used as a 
model organism.  S. cerevisiae, commonly known as baker’s or brewer's yeast, is the simplest 
eukaryotic model organism, and is non-pathogenic, yet mimics the pathogenic traits of adhesion and 
(pseudo)hyphae formation, so it can be employed to study pathogenesis.  Additionally, the genetic 
tools available for its manipulation are numerous, including ease of transformation with plasmids, and 
integration of DNA into the chromosomes via homologous recombination.  The fact that the genome 
has been sequenced, and systematic genomic deletion libraries are available is particularly appealing.  
Additionally, yeast exist in both haploid and diploid forms, allowing the researcher the ability to study 
recessive traits in haploids, and use meiosis to genetically link genotype to phenotype.  All of these 
aspects make yeast a desirable organism for study. 
 
 
 
 
- IAA 
+ IAA 
A. B. - IAA + IAA 
Figure 8: IAA inhibits growth, and induces filamentation in S. cerevisiae.  Panel A: A dilution 
series of yeast was spotted onto plates with and without IAA.  Plates containing high 
concentrations of IAA inhibit growth.  Panel B: The edge of a yeast patch grown on filamentation-
inducing media shows a change in phenotype due to exposure to IAA [18].   
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It has been proposed that when yeast is exposed to IAA, the transcription factor Yap1 translocates 
from the cytoplasm to the nucleus, where it regulates transcription of amino acid/auxin permeases 
(AAAPs, encoded by the AVTs in S. cerevisiae).  These permeases allow greater uptake of IAA into the 
cells.  Additionally, an increased level of Flo11 (a surface glycoprotein) is observed, which causes 
increased cell adhesion and filamentation  (Figure 9) [26].   
 
 
 
What is not yet known is the molecular mechanism by which the signal is transmitted.  In order to 
begin to address this question, a whole genome screen for mutants sensitive to IAA was performed 
(unpublished data).  Cells deficient in Grr1, an F-box protein homologous to IAA receptor Tir1 in 
plants, were identified as being hypersensitive to IAA.   
 
 
Tir1 and the SCF Complex 
Tir1 is an F-box protein that functions in the SCF complex which interacts with the plant hormone 
auxin.  This interaction mediates the proteosomal degradation of proteins that mediate the IAA 
response (Figure 10).   
 
Figure 9:  Maintenance of 
homeostasis:  Yap1 acts to regulate 
turnover of IAA transport proteins 
(AVTs).  Additionally, Flo11 is 
regulated, possibly by the same 
pathway.  The molecular mechanism 
of the pathway(s) remain unknown. 
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The SCF complex is made up of 4 molecules, Skp1, Cdc53/cullin, Rbx1/Roc1 and an F-box protein, 
which interact with ubiquitination enzymes.  The function of the SCF complex is to selectively 
ubiquitinate molecules for proteolytic degradation [27].   
 
 
 
This transcriptional regulation relies on auxin concentration to control the expression of genes.  When 
there is very little auxin present, it is unlikely to bind many of the repressors to Tir1, therefore the 
repressors do not get tagged for degradation.  When the auxin concentration reaches a particular 
threshold, the auxin, repressor and Tir1 are able to all bind, resulting in the tagging of the repressor 
for degradation.  This mechanism is not unlike the small molecule signaling previously described in 
bacterial systems.   
 
Low auxin concentration: Genes turned off 
Auxin response genes 
ARE 
 
IAA 
 IAA 
Auxin response genes 
ARE 
 SCF
Tir1
 
 IAA 
 
 
 
 
 
 
 
 
 
High auxin concentration: Genes turned on 
Figure 10:  Tir1 model.  When IAA is present at low concentrations, repressor proteins 
prevent the transcription of auxin response genes.  When IAA is present, it interfaces 
with TIR1 in the SCF complex to facilitate the binding of the AUX/IAA repressor proteins, 
leading to ubiquitination and subsequent degradation of repressors. 
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Figure 11:  Tir1, auxin, AUX/IAA protein interactions.  
Auxin binds in the concave surface formed by the 
leucine-rich repeat region.  Here, it acts as a “molecular 
glue” enabling the substrate (AUX/IAA repressor 
proteins) to bind Tir [28] 
In order to better understand the mechanism by which proteins are ubiquitinated by the SCFTir1 
complex, Tir1 was crystallized with auxin bound.  Two major hypotheses existed: auxin binds to an 
allosteric site, thus changing the conformation of the protein to allow binding of repressors- or, auxin 
enhances binding of the substrate to Tir1 
by enhancing surface interactions [28].  
The latter was determined to be true 
(Figure 11).  This model is the basis for 
our model of Grr1-IAA interactions in 
fungi. 
 
Grr1: the Fungal Homologue of Tir1 
There are 11 known F-box proteins in the yeast genome [29].  Grr1 is one of the very few of them to 
have been shown to associate with the SCF complex, and have substrates identified as targets for 
ubquitination, such as cell division control protein Cdc6 [30].  As early as 1996, it was shown that the 
SCF complex regulates transcription factors, such as Gcn4 [31].  Shortly thereafter it was shown that 
Grr1 regulates the cell cycle by mediating the degradation of cyclins Cln1 and Cln2 [32].  Additionally, 
it was observed that grr1∆ shows interesting phenotypes, such as decreased rate of growth and 
elongated cell morphology.  This led researchers to hypothesize that Grr1 mediates multiple pathways, 
likely through association with the SCF complex [32].  One of these additional functions was found to 
be in the glucose signal transduction pathway, where Grr1 has been shown to inactivate Rgt1, a 
repressor of glucose-induced genes [31].  Another pathway may be regulating the IAA-mediated 
virulence of fungi. 
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Aside from the F-box domain, which ubiquitinates proteins containing the degron sequence [29], Grr1 
has another conserved domain; the LRR domain.  This domain is frequently responsible for protein-
protein interactions.  In order to better understand the role of Grr1 in Cln1/2 regulation, the 
Wittenburg lab investigated the structure of Grr1.  Structural analysis of Grr1 revealed that the LRR 
region formed a characteristic horseshoe shape with an exceptionally high number of cationic charges 
on the concave surface [33].  This led them to focus on this region for their study. 
 
Mutational analysis of Grr1 included a carboxy-terminal deletion (CT∆), a leucine-rich repeat deletion 
(LR∆), and two more precisely targeted mutants, each with four basic residues on the aforementioned 
concave surface of the LRR mutated to either neutral glutamine (B4Q), or acidic glutamate (B4E).  All 
constructs were confirmed via RT-PCR and shown to produce protein by western blotting.  These 
studies revealed that the LRR and, to lesser extent, the C-terminus, were required for binding Cln1 and 
Cln2, and that this lack of binding was not due to the inability of the mutated protein to interact with 
the other SCF components [33].  When the LRR or C-terminus was deleted, the amount of Skp1 (an 
integral protein in the SCF complex) bound was decreased, leading them to conclude that while these 
mutants are still able to interact with the other SCF components, the nature of this interaction is likely 
modified [33].   
 
Furthermore, the cationic concave surface of the LRR has a higher affinity for phosphorylated Cln2 
protein, since the phosphate groups are negatively charged.  The B4E mutant did not interact with 
Cln2, likely because of the dramatic change in charge.  The B4Q mutant, however, interacted with Cln2 
at roughly the same frequency as the wildtype, probably due to its slightly less positive charge in the 
LRR region.  These data support the hypothesis that Cln2 interacts with positively charged concave 
surface of the LRR region of Grr1 [33].   
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Gic1 and Gic2 are phosphorylated proteins that interact with Grr1.  In the B4E and LR∆ mutants, levels 
of Gic1/2 were stabilized, suggesting the mutants cannot bind them in the SCF to promote their 
degradation.  This further supports the hypothesis that the cationic concave surface of the LRR is 
required for phosphorylated target identification/binding [33].   
 
Grr1: A Potential IAA Regulator 
 
Here we test the hypothesis that Grr1, a fungal F-box protein structurally similar to Tir1 (Figure 12) 
regulates IAA-mediated virulence traits, probably by facilitating the turnover of IAA transporters 
(Figure 9). 
 
 
 
The rationale for this hypothesis is based on the structural similarity of Grr1 and Tir1 (Figure 12), and 
the sensitivity profile of the grr1Δ mutant (Figure 7).  The goal of this thesis was to better understand 
the role of Grr1 in the regulation of IAA, through mutational analysis, and in a human pathogen, 
Candida albicans.   
  
Plant Tir1 
S. cerevisiaeGrr1 
C. albicansGrr1 
 
    
   
   
N-Terminus F-Box C-Terminus 
Leucine-Rich 
Repeats 
 
Figure 12:  Comparison of Grr1 proteins and Tir1.  F-box motif and leucine-rich repeat 
region are conserved in all three proteins, however length of both termini are highly 
variable.  Figure is drawn to scale. C. albicans Grr1 shares 46% identity and 64% similarity to 
S. cerevisiae Grr1 [36]. 
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Materials & Methods 
 
Media Preparation:  All media was prepared according to standard protocols [34].  Briefly, YPD Yeast 
Peptone Dextrose) consisted of 1% yeast extract, 2% peptone, 1% dextrose.  SC (Synthetic Complete) 
media contains yeast nitrogenous base and dropout mix with 2% dextrose, and only those amino acids 
required for strain growth added.  YNB (Yeast Nitrogenous Base) is the most limited media used, with 
only yeast nitrogenous base, 2% dextrose, and amino acids required for strain growth added.  To make 
plates of these varieties, 2% final concentration of agar was added.  SLAD plates consisted of 0.67% 
YNB, 0.05mM ammonium sulfate, 2% dextrose, and 2% washed agar.   
 
All plates containing IAA were mixed as described above, and appropriate volume of 1M IAA in 70% 
ethanol was added to cooled media, just before pouring the plates.  These plates were allowed to set 
for 7 days at room temperature in the dark before being used, and stored up to 7 additional days.    
 
IAA Sensitivity Assay:  All strains were grown in overnight cultures at 30°C in YPD media.  Cell density 
was normalized by diluting cultures with fresh YPD to OD600=1 (approximately 107 cfu/mL).  Cells were 
then washed with water, and 10 µL spots of a 1:10 dilution series (in water) were spotted on solid agar 
SC supplemented with appropriate amino acids, containing IAA (20 µM C. albicans, or 30 µM S. 
cerevisiae).  Control plates contained equal volume of the solvent (70% ethanol).  Images were 
acquired after two days of growth at 30°C. 
 
Adhesion Assay:  All strains were grown in overnight cultures at 30°C in YPD media.  Cell density was 
normalized by diluting cultures with fresh YPD to OD600=1 (approximately 107 cfu/mL).  Cells were then 
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washed with water.  For S. cerevisiae strains, 20 µL were spotted onto solid agar YPD, with 0.5 mM 
IAA.  For C. albicans strains, 20 µL were spotted onto solid agar SC supplemented with appropriate 
amino acids, with 100µM IAA.  All control plates contained an equal volume of solvent (70% ethanol).  
Spots were spread into triangular patches with a toothpick, taking care not to puncture the agar.  
Samples were grown at 30°C for two days, and then stored at 4°C overnight.  Plates were then washed 
under a stream of running water, and the surface was gently rubbed with a gloved finger.  This 
treatment continued until the water ran clear.  Images were acquired before and after washing.  
 
Strains: Yeast strains in Table 1 were used throughout this study. 
Lab 
Reference Strain Genotype Source 
Y769 sigma1278b MATa; ura3/ura3 C. Wittenberg 
Y770 grr1Δ 
ura3-52/ura3-52 leu2::hisG/leu2::hisGhis3; 
grr1::LEU2/grr1::LEU2 C. Wittenberg 
Y771 LRΔ 
ura3-52/ura3-52 leu2::hisG/LEU2his3::hisG/HIS3; 
grr1L::KanMX2/grr1L::KanMX2 C. Wittenberg 
Y772 CTΔ 
ura3-52/ura3-52 leu2::hisG/LEU2his3::hisG/HIS3; 
grr1C::KanMX2/grr1C::KanMX2 C. Wittenberg 
Y773 B4E 
ura3-52/ura3-52 leu2::hisG/LEU2his3::hisG/HIS3; 
grr1B4E::KanMX2/grr1B4E::KanMX2 C. Wittenberg 
SN250   
his1Δ/his1Δ, leu2Δ::C.dubliniensis HIS1 
/leu2Δ::C.maltosa LEU2, arg4Δ /arg4Δ, 
URA3/ura3Δ::imm , IRO1/iro1Δ::imm arg4Δ /arg4Δ, 
URA3/ura3Δ::imm , IRO1/iro1Δ::imm S. Noble 
grr1Δ grr1Δ/Δ grr1Δ/Δ in SN250 S. Noble 
Y101 BY4741 MATα ura3-52 trp1 leu2-3,112 ade2 his3Δ pho3-1 pho5-1 ([HIS4-lacZ, ura3-52]) S. Harashima 
Y681  MATα trp1-901 leu2-3, 112 ura3-52 his3-200 gal4∆ 
gal80∆ LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ E. Craig 
Table 1: Strains used in this study 
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In an attempt to quantify these data, ImageJ software was used.  First, the background intensity was 
found by acquiring three measurements of pixel intensity from the area immediately next to the 
triangle of growth and averaged.  Next, three measurements of pixel intensity were acquired from the 
center of the triangle of growth and averaged.  The average background was subtracted from the 
average growth to give one background adjusted value per triangle of growth.  This was repeated for 
all triangles on all plates.   
 
Next, to assess the adhesion of cells, the percentage of cells remaining post washing was calculated.  
In order to do this, the background adjusted values were compared for each plate, before and after 
washing, and represented as a percentage.   
 
These percentages met the assumptions of normality and homogeneity of variance for a two-way 
analysis of variance reasonably well.  The data were not transformed, as Zar [35] reports it is not 
warranted unless the largest sample size is greater than 5 times the smallest sample size.  In this case, 
the smallest sample size was 2, and the largest 6.   
 
Filamentation Assay:  All strains were grown in overnight cultures at 30°C in YPD media.  Cell density 
was normalized by diluting cultures with fresh YPD to OD600=1 (approximately 107 cfu/mL).  Cells were 
then washed with water, and 10 µL were spotted on SLAD plates with 20 µM IAA.  Control plates 
contained an equal volume of solvent (70% ethanol).  After 8 days of growth (S. cerevisiae), or 4 days 
of growth (C. albicans), at 30°C microscopic images of colony morphology were acquired. 
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Uptake Assay:  This whole-cell assay used C. albicans strains grown at 30°C until the OD600 was 0.4 in 
YNB, supplemented with required amino acids.  To measure IAA uptake, cells were harvested by 
centrifugation at 1,000 x g and were resuspended in MES (2-(N-morpholino) ethanesulfonic acid) 
buffer at pH 4.6 with 2% glucose.  Duplicate samples were removed after the addition of 
approximately 57 cells to 4 mL volume medium containing 5.2 µCi 3H-labeled IAA and 750 µM 
unlabeled IAA.  Approximately 6.256 cells were collected on glass-fiber filters at various time points, 
and were washed extensively with buffer.  The filters were placed in glass scintillation vials, were 
treated with 350 µl of 1 M NaOH for 10 minutes, and the solution was neutralized with 400 µl of 1 M 
acetic acid.  Uptake of labeled IAA into cells was determined by using 5 ml of liquid scintillation fluid.  
Averages were taken for 4 independent samples, standard deviation was calculated, and a T-Test was 
performed. 
 
 
Amplification of putative auxin response elements from yeast genome:  Y101 was used as template 
in standard PCR with the following conditions: 1X standard Taq buffer, 200 µM dNTPs, 0.25 µM each 
primer (Table 2), 1 μg/ml yeast DNA template, and 0.02 units/μL standard Taq, in a final volume of 200 
μL.  Samples were initially denatured at 95°C for 5 minutes, then cycled 30 times through a 94°C 
denaturation for 1 minute, 50°C annealing for 2 minutes, and 72°C extention for 2.5 minutes, followed 
by a final 5 minute extension at 72°C.  Samples were then purified via Qiaquick PCR spin columns, and 
eluted in 50 µL elution buffer.   
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Figure 13 :  pAUR112 cloning vector.  Vector 
was digested with SacI and a linker with SacI 
compatible ends and internal NotI was ligated 
in.   The NotI site was then used for ligation of 
PCR products with NotI compatible ends. 
[www.TaKaRa.com] 
Oligo Name Sequence (5’ to 3’) Distinguishing Features 
YCR102C-5’ AGTCATGCGAGCTCAGTGGCGGCCGCACT
TTGTATTTGTTTTGTTTGTTAG 
PCR product will contain NotI compatible 
ends  
YCR102C-3’ GATCATGCTCTAGACAGTGGCGGCCGCTTA
CGGTTTCTGGAATTGCAACTTG 
“ 
YLR460C-5’ AGTCATGCGAGCTCAGTGGCGGCCGCACT
TTGTATTTGTTTTGTTTGTTAG 
“ 
YLR460C-3’ GATCATGCTCTAGACAGTGGCGGCCGCTTA
CGTTTGTAGGTTATCTGTAATT 
“ 
YHL047C-5’ AGTCATGCGAGCTCAGTGGCGGCCGCACT
TAGACAAACGCCTTTACGAATG 
“ 
YHL047C-3’ GATCATGCTCTAGACAGTGGCGGCCGCTTA
CATTTCCTTTGGCCCAAAGAGT 
“ 
pYNL134C5’ AGTCATGCGAGCTCAGTGGCGGCCGCACT
TTGTGATGGCCTACACACTTCG 
“ 
pYNL1343’ GATCATGCTCTAGACAGTGGCGGCCGCTTA
CGCTTGATATGCAGTATGATAT 
“ 
Not1linker GCGGCCGCAGCT When annealed to self, contains one 
internal NotI site, and SacI compatible ends. 
Table 2: Oligonucleotides used in this study. 
 
Linker Insertion:  In order to ensure (virtually) any 
PCR product could be cloned into this system,  
pAUR112 was modified to have a unique NotI 
digestion site, where it previously had a SacI site 
(Figure 13).  NotI Linker was annealed by heating 
100 μL of 100 μM NotI linker oligos in TE to 95°C in a 
heat block.  When the block reached 95°C, it was 
turned off, and allowed to acclimate to room 
temperature (about 1 hour).  This linker contained a 
central NotI site, and had SacI compatible ends, to 
facilitate ligation into SacI digested pAUR112 with T4 
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ligase at room temperature overnight.  This construct was then transformed in DH5α cells according to 
manufacturer’s instructions.  Qiagen miniprep kit was used to purify samples, and insertion of NotI 
linker was confirmed via digest with NotI.   
 
Cloning putative AREs: PCR amplified AREs with NotI compatible ends, were ligated to NotI digested 
plasmid pAURNotI, at a ratio of approximately 6:1 (insert:plasmid) with 200 units T4 ligase in a final 
volume of 10 μL at room temperature overnight.  1 μL of this reaction was transformed into DH5α 
cells according to manufacturer’s instructions.   Qiagen miniprep kit was used to purify samples, and 
insertion of ARE was confirmed via various double digests, according to appropriate protocols from 
the manufacturer, and analyzed by gel electrophoresis. 
 
 
Yeast transformation: Each ARE containing plasmid, as well as unmodified plasmid (control) was 
transformed Y681 via standard lithium acetate methods [34].  Transformation was plated on selective 
media (SC-Ura) in order to select for yeast containing plasmid.   
 
 
Titration of Aureobasidin A:  All plasmids contain the AUR1-C gene for aureobasidin A (AbA) 
resistance, so minimal inhibitory concentration of AbA had to be empirically derived.  To do so, all 
strains were grown in overnight cultures at 30°C in YPD media.  Cell density was normalized by diluting 
cultures with fresh YPD to OD600=1 (approximately 107 cfu/mL).  Cells were then washed with water, 
and 10 μL spots of a 1:10 dilution series (in water) were spotted on solid agar SC containing up to 3.3 
µg/mL AbA.  After 2 days of growth at 30°C, images were acquired. 
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Promoting growth with IAA:  In order to evaluate the change in AbA growth inhibition in response to 
IAA, cells were prepared as described above, then spotted onto solid agar selective media (SC-Ura) 
containing 0.5μg/mL AbA and up to 50 µM IAA.  Images were acquired after two days of growth at 
30°C, and growth profiles were compared. 
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Results 
 
Yeast can synthesize, secrete, detect and respond to IAA.  When there is sufficient IAA in the 
environment, the yeast switch from a non-invasive yeast form to an invasive pseudohyphal form [18].  
In a whole genome screen, it was discovered that grr1Δ mutant is hypersensitive to IAA (unpublished).  
Previous work in the Rao lab revealed that this hypersensitivity correlated with increased uptake of 
IAA (Unpublished data). 
 
The goal of this thesis was to investigate the role of Grr1 in regulating IAA-mediated virulence 
phenotypes, by identifying the domain(s) of Grr1 required for IAA response in Saccharomyces 
cerevisiae.  Next, I tested the hypothesis that Candida albicans Grr1 is the functional homologue of S. 
cerevisiae Grr1, as they share 46% identity and 64% similarity [36].  Finally, I wanted to identify cis-
regulatory elements that respond to IAA. 
 
Phenotypic Characterization of grr1 Mutants in Saccharomyces cerevisiae 
Previously, the Rao lab had shown grr1Δ was sensitive to IAA, presumably because it takes up more 
IAA.  Therefore, I chose to investigate several Grr1 mutants (Table 1).  These mutants were a gift from 
Curt Wittenberg of the Scripps Institute [33].   
 
The Grr1 protein is composed of several recognizable domains and regions (Figure 14).  First, the F-box 
motif is vital for the function of Grr1 in the SCF complex.  Here, it is responsible for target 
identification for the ubiquitin mediated degradation of proteins.  The next known motif is the 
leucine-rich repeat region.  This region forms a characteristic horse-shoe shape, and is typically 
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Figure 14: GRR1 gene structure.  Mutants used for this study include leucine-rich repeat 
region deletion (LRΔ), carboxy terminus deletion (CTΔ), and a mutant with 4 point mutations, 
altering basic residues to acidic glutamate (B4E, indicated by *) [33] 
involved with substrate binding in other proteins [28,33].  The F-box and LRR region are preceded by a 
large N-terminus and followed by a large C-terminus, the function of which is currently unknown.  The 
homology of fungal Grr1 and plant Tir1 is limited to the F-box and LRR regions.   
 
The first mutant used in this study was the leucine-rich repeat region deletion (LR∆).  This was of 
interest because the LRR region is a common site for protein-protein interactions.  Next was the C-
terminal deletion (CT∆), of interest due to its large size, and unknown function.  The last mutant of 
interest is the most subtle; four basic residues on the concave surface of the leucine-rich repeat region 
have been mutated to acidic glutamate (B4E).  In molecular modeling, these four basic residues were 
predicted to protrude into the pocket made by the leucine-rich repeat region.  By changing the charge 
so dramatically, this mutant was expected to show a distinct phenotype [33]. 
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Figure 15:  GRR1 mutants are 
more sensitive to IAA.  
Samples were spotted at 
OD600 = 1, and a 1:10 dilution 
on plates containing IAA.  
+ IAA 
CT Δ 
-IAA 
LR Δ 
grr1 Δ 
WT 
B4E 
 
1 1 1:10 1:10 
B4E Mutant is Hypersensitive to IAA 
grr1Δ has been previously shown to be more sensitive than wildtype to IAA-induced growth inhibition 
(Unpublished data).  By testing various subtle mutations in the Grr1 protein, it could be determined  
which regions of the gene are responsible for this phenotypic change.  10-fold dilutions of overnight 
cultures were spotted on IAA-containing plates and incubated at 30°C for 2-3 days.  Growth of all 
mutants (except for grr1∆) was indistinguishable from wildtype in the absence of IAA.  The B4E and 
grr1∆ mutants were severely inhibited in their ability to grow in the presence of IAA.    In contrast, the 
LR∆ appeared to be slightly resistant to the effects of IAA, exhibiting more growth than the wildtype.  
Lastly, the CTΔ mutant was indistinguishable from the wildtype.  
Figure 15 shows a representative micrograph, and the trend was 
observed over several replications (over 10 times).  These results 
suggest that the C-terminus is not required for IAA-induced 
growth inhibition.  The apparent discrepancy between the IAA-
resistant LRΔ and IAA-sensitive B4E mutants is noteworthy.  The 
B4E mutant was indistinguishable from the grr1Δ mutant, while 
the LRΔ was not.  This suggests that four point mutations in the 
LRR region render the protein inactive, while deleting the entire 
LRR region does not.   
 
B4E mutant shows pseudohyphal formation in response to IAA 
 Pseudohyphal growth is a foraging response associated with increased virulence.   In order to better 
characterize IAA-mediated pseudohyphal growth, all mutants were grown in overnight cultures, then 
spotted on minimal media plates containing sub-inhibitory concentrations of IAA.  After eight days of 
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Figure 16:  IAA induces filamentation in GRR1 mutants.  Overnight cultures were spotted and 
grown on plates containing IAA, and then the edge of the colony was observed.  The no IAA 
control shows that the CTΔ and B4E mutants are slightly hyperfilamentous.  IAA increases in the 
amount of filamentation present in the grr1Δ and the B4E mutants.   
 
LRΔ grr1Δ *B4E  CTΔ Wildtype 
-IAA 
+IAA 
Scale bar: 10µm 
 
growth in the dark (to prevent photodegradation of IAA), microscopic images were acquired to 
analyze colony morphology and pseudohyphal growth.  The experiment was repeated several times, 
and a representative image is shown below (Figure 16). The CTΔ and B4E mutant were slightly 
hyperfilamentous, as observed by the minimal filamentation present in the absence of IAA; however, 
at a low concentration of IAA which does not enhance filamentation in the wildtype, the grrΔ and B4E 
mutants filamented extensively.  In contrast, the wildtype, LRΔ and CTΔ cells did not respond to IAA.  
All strains were able to filament at higher concentrations of IAA, suggesting that these mutants are 
capable of filamentous growth; they are simply not responding to the low level of IAA they are 
exposed to.  These data are congruent with the previous growth inhibition data; the B4E mutant 
showed filamentation patterns similar to those of the grr1Δ mutant.  Again of note, the LRΔ 
phenotype was more similar to the wildtype than the B4E mutant, suggesting that mutating four 
residues within the LRR region abolishes protein activity, but removing the entire LRR region does not.   
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Figure 17:  IAA induces adhesion of GRR1 mutants.  Overnight samples were patched  on plates 
containing IAA, and grown for 2 days.  The plates were then washed under running water.   Panel A:  
The no IAA control shows that all mutants adhered slightly to the plates.  When IAA was present in the 
plates, the amount of adhesion increased in the grr1Δ.  Panel B:  ANOVA followed by Tukey post-hoc 
tests revealed grr1Δ  +IAA is significantly different from all other groups (p <0.05) 
B4E mutant grows invasively in response to IAA 
Low levels of IAA enhance grr1Δ surface adhesion [18], an important virulence phenotype.  To 
determine which region(s) of the protein is required for this response, subtle mutations of Grr1 were 
grown in overnight cultures and patched onto rich media agar plates containing IAA.  Next, the non-
adherent cells were washed away by gently rubbing the surface of the agar under running water.  It 
was observed that the agar surface beneath the grr1Δ and B4E mutant growth patches on IAA plates 
were textured, where the other samples, and plates lacking IAA, felt smooth and undisturbed.  The 
micrographs are representative of several repetitions, which showed the same trend (Figure17A).  All 
mutants showed increased adhesion without IAA, but only the grr1Δ mutant showed quantifiable IAA 
induced adhesion in this assay (Figure 17B).  These data suggest that IAA induces surface adhesion in 
the grr1Δ mutant, and possibly causes some change in B4E mutant adhesion behavior, as observed by 
the change in agar surface texture.  
A 
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Figure 18:  grr1Δ/Δ is sensitivite to 
IAA.  Samples were spotted at OD600 
= 1, and a 1:10 dilution on plates 
containing IAA.    
In summary, the B4E mutant phenocopied the grr1∆ mutant, with regard to IAA response.  This is an 
important discovery, because it shows that the structural integrity of the protein is required for proper 
ability to respond to IAA.  Since IAA mediates virulence responses, this knowledge could help with the 
development of a new drug target. 
 
The Role of Grr1 in the Regulation of IAA in the Human Pathogen Candida albicans 
To investigate whether the mechanism of IAA regulation was conserved in pathogenic fungi, I 
evaluated the IAA response of C. alibicans grr1Δ/Δ mutants.  The grr1Δ/Δ mutant was obtained from 
the stock center (Table 1) [37]. 
 
IAA inhibits growth of C. albicans grr1Δ/Δ mutants 
S. cerevisiae and C. albicans Grr1 are structurally similar (Figure 12).  In order to determine whether 
they were functionally similar, the Candida albicans grr1Δ/Δ mutant was investigated for IAA 
sensitivity.  Candida albicans grr1Δ/Δ mutant is sensitive to IAA (Figure 18), similar to S. cerevisiae 
grr1Δ (Figure 14).  Overnight cultures of the strains were grown, and dilutions were spotted onto 
plates containing IAA.  Growth patterns were observed after 2 and 3 days of growth.  The grr1Δ/Δ 
mutant grows slightly less than the wildtype when no 
exogenous IAA is added, likely due to the effects of Grr1 
on cell cycle regulation.  A much greater difference, 
however, is noted when comparing the grr1Δ/Δ mutant to 
the isogenic wildtype strain in the presence of IAA.  Here, 
IAA has severely suppressed growth in the mutant, but 
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Figure 19:  IAA induces filamentation in grr1Δ/Δ.  
Overnight cultures were spotted and grown on plates 
containing IAA, then the edge of the colony was 
observed.  grr1Δ/Δ responds to low levels of IAA, while 
no change is observed in the wildtype. 
only had a very modest effect on the wildtype.  Figure 18 shows a representative micrograph, and the 
trend was observed over several replications.  These results suggest that Grr1 plays a vital role in IAA 
mediated inhibition of growth in C. albicans. 
 
IAA induces hyphae formation in C. albicans grr1Δ/Δ mutants.  
Filamentation is required for pathogenic 
fungi to penetrate host membranes, and 
thus is an important virulence phenotype.  
In S. cerevisiae, filamentation is induced by 
IAA.  In order to determine whether the 
grr1Δ/Δ mutant is sensitized to IAA, 
filamentation of the mutant was observed 
in the presence and absence of IAA.  
Filamentation is induced in C. albicans 
grr1Δ/Δ at sub-inhibitory concentrations of 
IAA, similar to S. cerevisiae grr1Δ mutant 
(Figure 16).  Filamentation of strains patched on minimal media were observed microscopically after 4 
days of growth (Figure 19).  The experiment was repeated several times, and a representative image is 
shown below.  The micrograph in Figure 18 shows that at low concentrations of IAA that do not affect 
wildtype cells, the grr1Δ/Δ are affected, suggesting that the grr1Δ/Δ has been sensitized to IAA, and 
can detect low concentrations of IAA that the wildtype cells cannot.  
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Figure 20:  IAA induces surface adhesion of grr1Δ/Δ.  Overnight 
cultures were patched on plates containing IAA, and then grown for 2 
days.  The plates were then washed under running water.   The no IAA 
control shows that the mutant adhered slightly more to the plates.  
When IAA was present in the plates, the amount of adhesion 
increased in the grr1Δ/Δ mutant, while no change was seen in the 
wildtype. 
Washed WT 
WT Unwashed 
- IAA +IAA 
WT 
Δ/Δ WT 
 
Δ/Δ 
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IAA induces invasive growth in C. albicans Grr1Δ/Δ mutant. 
Adhesion is the first step of infection, and the S. cerevisiae grr1Δ mutant showed increased surface 
adhesion in response to IAA (Figure 17).  In order to test whether C. albicans grr1Δ/Δ mutant mimics 
this phenotype of their counterpart in S. cerevisiae, overnight cultures were grown, and then patched 
onto plates containing IAA and allowed to grow for two days.  Next, the non-adherent cells were 
washed away by gently rubbing the agar under running water.  At low concentrations of IAA, grr1Δ/Δ 
cells adhere to the agar surface, 
while wildtype wash off (Figure 
20).  Since this response to IAA is 
considered a foraging response, 
there is a known “edge-effect” 
where the cells around the edge 
are not nutrient deprived, while 
the center of the patch is starved 
and therefore responds to IAA.  
These data indicate that Grr1 
regulates the surface adhesion of 
cells treated with IAA. 
 
IAA uptake is increased in C. albicans grr1Δ/Δ mutant. 
Phenotypic characterization of grr1Δ/Δ mutant suggests it is more responsive to IAA than its wildtype 
counterpart (Figures 18-20).  This result is consistent with the hypothesis that IAA can enter the 
mutant cells more easily than wildtype cells.  To test this hypothesis, IAA uptake was measured by a 
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radioactivity filter binding assay [18].  The grr1∆/∆ accumulates twice as much IAA as the wildtype 
(Figure 21), presumably by up-regulating putative IAA transporters.  The AAP (amino acid permease) 
proteins in C. albicans are homologous to the AAAP (or AVT) transporters of S. cerevisiae.  This 
information, together with the mutant analysis of C. albicans grr1∆/∆, suggests that C. albicans Grr1 is 
a functional homologue of Grr1 in S. cerevisiae.  This information implies that by decreasing IAA 
uptake in cells via the AAP transporters, virulence traits may be controlled. 
 
 
 
In summary, the Candida albicans grr1∆/∆ mutant mimics the IAA phenotypes of the S. cerevisiae 
grr1∆ mutant with regards to the virulence traits of adhesion and filamentation, in response to IAA.  
This information suggests that S. cerevisiae can be used as a model organism to study fungal 
pathogenesis, and that Grr1 plays a vital role in IAA-induced virulence traits. 
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Figure 21: IAA uptake is increased in grr1 mutant.    Overnight 
cultures were freshly diluted and grown until log phase.  Cells were 
harvested, and then incubated with radiolabeled IAA.  Cells were 
then filtered, washed, and radioactivity was measured.  Error bars 
indicate one standard deviation from the mean.  P<0.001 
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Identification of Cis-regulatory elements in S. cerevisiae 
IAA regulates gene expression in plants via auxin response factors, ARFs, which are trans-acting 
factors, and auxin response elements, AREs, which are cis-acting sequences.  We know that IAA gets 
into S. cerevisiae cells (unpublished data) and results in phenotypic changes that are indicative of 
increased virulence (Figures 14-16).  Therefore, we believe that IAA probably regulates transcription 
factors (analogous to ARFs) that in turn regulate gene expression.  These transcription factors likely 
bind to specific DNA sequences (analogous to AREs).  To identify putative AREs, we analyzed the 5’ 
intergenic regions of genes that were upregulated in response to IAA (Unpublished microarray data).  
Four genes (YCR102C, YLR460C, YHL047C, and YNL134C) (Table 3) that were expressed over two times 
above standard deviation were chosen for further analysis.   
 
Gene Locus 5’ Upstream Region 
(putative ARE) Size 
Description of Upregulated Genes 
YCR102C 2332 bp Similar to C. carbonum toxD gene, member of the 
quinone oxido reductase family [38-40] 
YLR460C 2030 bp Member of the quinone oxido reductase family, up-
regulated in response to the fungicide mancoze [39-
41] 
YHL047C 1708 bp Transporter, member of the ARN family of 
transporters that specifically recognize siderophore-
iron chelates; responsible for uptake of iron bound to 
the siderophore triacetyl fusarinine C [42,43] 
YNL134C 567 bp Similarity to dehydrogenases [44-46] 
Table 3: Putative auxin response elements 
 
These intergenic regions (the sequence upstream of the target gene until the stop codon of the 
previous gene) were ligated into a reporter construct (modified pAUR112, see Materials and Methods 
for full description) upstream of the antibiotic (aureobasidin) resistance gene (AUR1-C) (Figure 13).  If 
a transcription factor (such as an ARF) were to bind the putative ARE, the AUR1-C gene for antibiotic 
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Figure 22: Concentration of aureobasidin A required to inhibit 
growth.  Overnight cultures were spotted on plates containing 
antibiotic ranging from 0 to 3.3µg/mL.  Panels A, B and C exhibit 
growth inhibition at 0.5µg/mL.  Panel D exhibits no growth 
inhibition at the maximum tested concentration. 
Aureobasidin A (µg/mL) 
YLR460C 
0.1 0.5 0 
1:100 
1:10 
 
B 
1:100 
0.1 0.5 0 
YHL047C 
1:10  
C Aureobasidin A (µg/mL) 
YNL134C 
0.5 3.3 0 
1:100 
1:10 
 
D Aureobasidin A (µg/mL) 
0.5 0 
1:100 
1:10 
YCR102C 
 
A Aureobasidin A (µg/mL) 
resistance would be activated.  Construct orientation was verified via endonuclease double digests.  
These constructs were then transformed into Saccharomyces cerevisiae, along with stock pAUR112 
plasmid (negative control).  These samples were grown overnight, and spotted onto plates containing 
up to 3.3µM antibiotic.  Aureobasidin at 0.5µg/mL was sufficient to inhibit growth in all samples, 
except YNL134C.  This construct was not inhibited by up to 3.3 µg/mL concentration of aureobasidin 
(Figure 22).  It was concluded that 
the reporter construct containing 
the upstream sequence of YNL134C 
could not be used for this study 
because it likely contains the 
binding site for another 
transcription factor, which 
constitutively turned on the 
antibiotic resistance gene.  For this 
reason, only three reporter 
constructs, with the upstream 
sequences of YCR102C, YLR460C, 
and YHL047C, were pursued.  
 
We anticipated that these sequences should respond to IAA.  To test this hypothesis, samples were 
spotted onto plates containing increasing concentrations of IAA, and a constant concentration of 
antibiotic.  The construct containing the putative upstream regulatory region of gene YLR406C showed 
increased growth in response to increased IAA.  The empty vector control, and the other three regions 
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Figure 23: Upstream sequence YLR460C 
activates alternative gene expression in 
response to IAA.  Overnight cultures were 
spotted on plates containing no antibiotic and no 
IAA (positive control), antibiotic and no IAA 
(negative control), and plates with antibiotic, 
and increasing concentrations of IAA.  YLR460C 
showed a dose-dependent response to IAA. 
were not able to express enough of the 
antibiotic resistance gene to overcome the 
antibiotic in the plates (Figure 22).  These data 
indicate that there may be a transcription 
factor that is regulated by IAA, and binds 
upstream of gene YLR406C in order to regulate 
expression. Future directions for this work 
would be to use this construct in a yeast 1 
hybrid screen, in order to identify this putative 
transcription factor.  
44 
 
Discussion 
 
In summary, Grr1 is critical for fungal response to IAA, potentially as a soluble receptor.  Changing four 
basic residues to acidic glutamate in the LRR region abolishes Grr1 activity.  I propose that this is due 
to a conformational change in the protein structure which renders the active site inaccessible.  
Additionally, the similar IAA induced phenotypic changes observed in both fungi provide strong 
evidence that Candida albicansGrr1 is the functional homologue of Saccharomyces cerevisiae Grr1. 
 
The purpose of this thesis was to investigate the molecular mechanism of IAA (the plant hormone 
auxin) regulation in fungi, specifically, Saccharomyces cerevisiae and the human pathogen Candida 
albicans.  It has been established that S. cerevisiae synthesize IAA in both a tryptophan dependent and 
tryptophan independent manner [25], secrete IAA into the environment, transport IAA into the cells, 
and respond to IAA in several ways, including filamentation, surface adhesion, and growth inhibition 
(Figures 15-17).  I focused my effort on evaluating the contribution of Grr1 to IAA regulation.  Grr1 is 
an F-box protein homologous to the IAA receptor Tir1 in Arabadopsis thaliana.  This homology 
suggests that Grr1 may play a similar role in fungi.  Deleting grr1 in S. cerevisiae has been shown to 
sensitize cells to IAA, but what remained to be shown was the specific domain(s) involved in the IAA 
response.   
 
Tir1 is an F-box protein in the SCF complex.  This complex is responsible for the degradation of 
AUX/IAA proteins (transcriptional repressors).  The interaction between Tir1 and the AUX/IAA proteins 
is only made possible by the presence of IAA, which acts as a “molecular glue,” filling a pocket in the 
Tir1 leucine-rich repeat region (Figure 11).  By filling this cationic gap, the surface area for binding is 
increased, and degradation of the AUX/IAA proteins is possible [33].   
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Saccharomyces cerevisiae GRR1 is quite similar to Tir1, and previous work in the Rao lab indicates that 
the grr1Δ mutant is hypersensitive to IAA.  It was hypothesized that Grr1 may be the functional 
homologue to Tir1.  Several mutants were surveyed to determine the regions required for IAA 
response.  Given that the leucine-rich repeat region of Tir1 forms a pocket where IAA binds, the 
leucine rich repeat region was a target of interest in this study.   
 
Surprisingly, deleting the leucine-rich repeat region resulted in a phenotype virtually indistinguishable 
from the isogenic wildtype.  Meanwhile, four point mutations in the LRR region (B4E protein) resulted 
in a phenotype virtually indistinguishable from the grr1Δ mutant in all phenotypic tests.  Combined 
with the (previously known) fact that B4E protein is produced just fine [33], this suggests that the 
conformational change has affected the availability of the active site of the protein.   
 
One of the main differences between plant Tir1 and yeast Grr1 is the carboxy terminal region (Figure 
12).  The C-terminus of Grr1 is substantially longer than that of Tir1, and its function is unknown.  The 
C-terminal deletion mutant was slightly hyperfilamentous in the absence of IAA, however, when 
exposed to IAA, it showed no phenotypic change (akin to the wildtype response to IAA), suggesting 
that the carboxy terminal region of Grr1 is not involved in IAA response.   
 
Candida albicans Grr1 is a functional homologue of Saccharomyces cerevisiae Grr1 with regard to IAA 
regulation.  All of the assays performed on the S. cerevisiae mutants were performed on the C. 
albicans grr1Δ/Δ mutant, and all IAA-related phenotypes were recapitulated in the Candida albicans 
grr1Δ/Δ mutant: increased IAA sensitivity; filamentation and surface adhesion were increased in 
response to IAA; IAA uptake was increased in the grr1Δ/Δ mutant when compared to wildtype. 
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Figure 24: Proposed molecular model of Grr1 mediated IAA response.   
Panel A: In wildtype cells, IAA homeostasis maintained by proper regulation of IAA uptake 
carriers. 
Panel B: In grr1∆ cells, the SCF complex cannot function to relieve transcriptional inhibition 
of transcription factors that are responsible for the downstream degradation of uptake 
carriers. 
While this thesis presents clear indication that Grr1 regulates IAA response in both Saccharomyces 
cerevisiae, and Candida albicans, there is still much work to be done in order to better understand the 
molecular mechanism by which Grr1 regulates fungal response to IAA.  The most parsimonious model 
that explains the phenotypic consequences of grr1Δ is that the F-box ubiquitin ligase protein Grr1 
indirectly regulates the turnover of IAA transporters (AVT genes in S. cerevisiae) [18].  As cell surface 
proteins in S. cerevisiae are turned over by endocytosis, not by the proteasome, Grr1 probably does 
not recruit these AVTs to the proteasome.  Like the Tir1 model (Figure 10), Grr1 likely functions 
through an intermediary, which in turn regulates levels of the transporters (Figure 24).  For instance, 
Grr1 may tag a repressor protein that inhibits the transcription of the transcription factor Yap1 for 
degradation in the presence of IAA.  Yap1 has been shown to negatively regulate the AVT transporters 
[18].  Thus, IAA-mediated activation of Grr1 releases the repression of a transcription factor, such as 
Yap1, resulting in the increase of IAA uptake carriers.  Using this model, it follows that when Grr1 is 
not active, the repressor of the transcription factor will not be degraded, and no transporters will be 
degraded.  This will result in an accumulation of transporters on the membrane, and cells that are 
hypersensitive to IAA.  This is congruent with the data that has been presented here. 
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Future directions for this work are numerous.  First, in order for Grr1 to be a receptor for IAA, it must 
bind IAA. In order to confirm the hypothesis that Grr1 is the receptor for IAA in yeast, a pull down 
assay followed by a binding assay should be performed.  Briefly, recombinant GST-IAA will be 
expressed in E. coli, and purified using glutathione beads.  Meanwhile, Grr1 will be cloned into yeast, 
and expressed in the presence of 35S translabel, resulting in radiolabeled Grr1.  If Grr1 binds IAA, 
incubating the beads together with the labeled Grr1 should result in labeled beads [47]. 
 
Next, the working model is that Grr1 regulates the turnover of IAA uptake carriers.  In order to confirm 
this hypothesis, GFP tagged Avt proteins can be tracked in the grr1Δ mutant by fluorescent 
microscopy.  Increased accumulation of Avt proteins in the grr1Δ compared to isogenic wildtype 
would support our hypothesis (Figure 24).   
 
Lastly, I have shown that the active site for IAA is not likely to be located in the carboxy terminal region 
or the LRR region of Grr1 (Figures 15-17).  As the F-box motif is required for association with the SCF 
complex, it is unlikely that the active site for IAA is located within it.  If an N-terminal deletion strain 
were constructed, it could be determined whether this is where the active site for IAA is located.  
Once this is determined in Saccharomyces cerevisiae, it would be interesting to see whether the active 
site is located in the same place in Candida albicans, as their N-terminal regions are so different in 
length (Figure 12).   
 
These results are consistent with the hypothesis that IAA is a small molecule signal that regulates 
virulence in the human pathogen C. albicans.  This is an important finding, as is provides us an avenue 
to understanding how fungal pathogens are communicating to turn on virulence traits.  Developing a 
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strategy to disrupt this communication may be a method of treating the ever growing public health 
problem of drug resistant fungal infections.   
 
One particularly appealing aspect of this new potential antifungal drug target is that it does not 
necessarily require the entry of the drug into the yeast cells.  One main mechanism by which yeast 
gain resistance to drugs is by developing pumps to excrete the drugs.  If the drugs cannot build up in 
the pathogen, the pathogen cannot be affected.  As IAA is secreted from the cells, the drug target 
could be extracellular.  This would mean the mechanism of developing efflux pumps would have no 
effect on the drugs ability to work.    
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